SMECTITE IN ACUTE DIARRHEA IN CHILDREN - A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL

被引:56
|
作者
MADKOUR, AA
MADINA, EMH
ELAZZOUNI, OEZ
AMER, MA
ELWALILI, TMK
ABBASS, T
机构
[1] UNIV ALEXANDRIA,FAC MED,ALEXANDRIA,EGYPT
[2] MOSTAFA KAMEL MIL HOSP,ALEXANDRIA,EGYPT
关键词
SMECTITE; ADSORBENTS; ANTIDIARRHEAL; ACUTE DIARRHEA; DIARRHEA MANAGEMENT;
D O I
10.1097/00005176-199308000-00008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Dioctahedral smectite (DS) a natural adsorbent clay capable of adsorbing viruses, bacteria, and other intestinal irritants in.vitro, is claimed to possess beneficial ''antidiarrheal'' properties. This study tested the effect of DS on the duration of diarrhea and the frequency and amount of liquid stools. Ninety well-nourished boys, aged 3-24 months, with acute watery diarrhea and mild, moderate, or severe dehydration were included in a randomized double-blind, placebo-controlled trial. After initial rehydration, they received DS or placebo (1.5 g freshly dissolved in 50 ml of water, four times daily for 3 days) along with oral rehydration solution (ORS) and adequate feeding. The clinical characteristics of both groups were comparable on admission. Patients in the smectite group had a significantly shorter duration of diarrhea (mean +/- SD, 54 +/- 16 vs. 73 +/- 13 h) and significantly fewer stools (2.6 +/- 0.8 vs. 3 +/- 0.7 on second day; 1.9 +/- 0.7 vs. 2.4 +/- 0.7 on third day; and 11.3 +/- 3.2 vs. 13.8 +/- 3 overall). The amount of liquid stools was not significantly reduced. Weight gain at 24, 48, and 72 h and on recovery was significantly higher in the smectite group despite the comparable fluid and food intake in both groups. These results suggest a beneficial effect of DS in shortening the duration of diarrhea and reducing the frequency of liquid stools in children rehydrated with ORS.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 50 条
  • [41] Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
    Walter, Maggie C.
    Reilich, Peter
    Thiele, Simone
    Schessl, Joachim
    Schreiber, Herbert
    Reiners, Karlheinz
    Kress, Wolfram
    Mueller-Reible, Clemens
    Vorgerd, Matthias
    Urban, Peter
    Schrank, Bertold
    Deschauer, Marcus
    Schlotter-Weigel, Beate
    Kohnen, Ralf
    Lochmueller, Hanns
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [42] Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial
    Sharma, PK
    Yadav, TP
    Gautam, RK
    Taneja, N
    Satyanarayana, L
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (02) : 241 - 244
  • [43] CISAPRIDE IN CHILDREN WITH CHRONIC INTESTINAL PSEUDOOBSTRUCTION - AN ACUTE, DOUBLE-BLIND, CROSSOVER, PLACEBO-CONTROLLED TRIAL
    DILORENZO, C
    REDDY, SN
    VILLANUEVAMEYER, J
    MENA, I
    MARTIN, S
    HYMAN, PE
    GASTROENTEROLOGY, 1991, 101 (06) : 1564 - 1570
  • [44] ORAL ZINC FOR THE TREATMENT OF ACUTE GASTROENTERITIS IN CHILDREN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Patro, B.
    Szymanski, H.
    Szajewska, H.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E213 - E213
  • [45] A CONTROLLED DOUBLE-BLIND CLINICAL-TRIAL OF NICARDIPINE VERSUS PLACEBO IN ACUTE FOCAL CEREBRAL-ISCHEMIA
    GAMEZ, NM
    MAS, JAS
    MARTINEZ, JLA
    GARCIA, JMB
    SALIM, A
    JIMENEZ, AR
    EXTREMERA, BG
    MEDICINA CLINICA, 1988, 90 (17): : 690 - 692
  • [46] Ebselen in acute middle cerebral artery occlusion: A placebo-controlled, double-blind clinical trial
    Ogawa, A
    Yoshimoto, T
    Kikuchi, H
    Sano, K
    Saito, I
    Yamaguchi, T
    Yasuhara, H
    CEREBROVASCULAR DISEASES, 1999, 9 (02) : 112 - 118
  • [47] Efficacy of fructooligosaccharide versus placebo for treatment of acute diarrhea in children: A double-blind randomized clinical trial
    Suryanty, Reni
    Supriatmo
    Hasibuan, Berlian
    Sinuhaji, Atan Baas
    PAEDIATRICA INDONESIANA, 2005, 45 (3-4) : 65 - 68
  • [48] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF KETAZOLAM IN ANXIETY
    BOWDEN, CL
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1978, 24 (02): : 170 - 178
  • [49] NIFEDIPINE FOR EPILEPSY - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    LARKIN, JG
    BESAG, FMC
    COX, A
    WILLIAMS, J
    BRODIE, MJ
    EPILEPSIA, 1992, 33 (02) : 346 - 352
  • [50] BROMOCRIPTINE IN MANIA - PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL
    SMITH, AHW
    CHAMBERS, C
    NAYLOR, GJ
    BRITISH MEDICAL JOURNAL, 1980, 280 (6207): : 86 - 86